The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Role of Chemokines in Endocrine Autoimmune Diseases
Abstract
Chemokines are a group of peptides of low molecular weight that induce the chemotaxis of different leukocyte subtypes. The major function of chemokines is the recruitment of leukocytes to inflammation sites, but they also play a role in tumoral growth, angiogenesis, and organ sclerosis. In the last few years, experimental evidence accumulated supporting the concept that interferon-γ (IFN-γ) inducible chemokines (CXCL9, CXCL10, and CXCL11) and their receptor, CXCR3, play an important role in the initial stage of autoimmune disorders involving endocrine glands. The fact that, after IFN-γ stimulation, endocrine epithelial cells secrete CXCL10, which in turn recruits type 1 T helper lymphocytes expressing CXCR3 and secreting IFN-γ, thus perpetuating autoimmune inflammation, strongly supports the concept that chemokines play an important role in endocrine autoimmunity. This article reviews the recent literature including basic science, animal models, and clinical studies, regarding the role of these chemokines in autoimmune endocrine diseases. The potential clinical applications of assaying the serum levels of CXCL10 and the value of such measurements are reviewed. Clinical studies addressing the issue of a role for serum CXCL10 measurement in Graves’ disease, Graves’ ophthalmopathy, chronic autoimmune thyroiditis, type 1 diabetes mellitus, and Addison’s disease have been considered. The principal aim was to propose that chemokines, and in particular CXCL10, should no longer be considered as belonging exclusively to basic science, but rather should be used for providing new insights in the clinical management of patients with endocrine autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
Properties Of The Novel Proinflammatory Supergene Intercrine Cytokine Family
Oppenheim, J. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.617 · Cited by 1,877
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes
Sallusto, F., Lenig, D., Mackay, C. R., & Lanzavecchia, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.875 · Cited by 1,542
Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties
Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., & Murphy, K. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.002 · Cited by 1,422
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,379
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,263
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M., & Hengartner, H. (1991) · Cell · doi:10.1016/0092-8674(91)90164-t · Cited by 1,173
The aging immune system: primer and prospectus
Miller, R. A. (1996) · Science · doi:10.1126/science.273.5271.70 · Cited by 1,165
Romagnani, S. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80019-9 · Cited by 1,078
Self-citationDufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., & Luster, A. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3195 · Cited by 1,075
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Sørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., & Leonard, E. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9233 · Cited by 982
Molecular cloning of gene sequences regulated by platelet-derived growth factor
Cochran, B. H., Reffel, A. C., & Stiles, C. D. (1983) · Cell · doi:10.1016/0092-8674(83)90037-5 · Cited by 945
Luster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Lymphoid neogenesis in chronic inflammatory diseases
Aloisi, F., & Pujol-Borrell, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1786 · Cited by 908
Pearce, E. N., Farwell, A. P., & Braverman, L. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021194 · Cited by 878
Miyamoto, K., Miyake, S., & Yamamura, T. (2001) · Nature · doi:10.1038/35097097 · Cited by 874
Cole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2009 · Cited by 870
Balashov, K. E., Rottman, J. B., Weiner, H. L., & Hancock, W. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6873 · Cited by 849
Weetman, A. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010263431707 · Cited by 834
Jose, P. J., Griffiths-Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., & Williams, T. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.881 · Cited by 806
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 778
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
Su, C. G., Wen, X., Bailey, S. T., Jiang, W., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., & Wu, G. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7145 · Cited by 767
Betterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758
Matsushima, K., Larsen, C. G., DuBois, G. C., & Oppenheim, J. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1485 · Cited by 756
Oldstone, M. B. A., Nerenberg, M., Southern, P., Price, J., & Lewicki, H. (1991) · Cell · doi:10.1016/0092-8674(91)90165-u · Cited by 751
Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021897 · Cited by 739
Self-citationMourits, M. P., Koornneef, L., Wiersinga, W. M., Prummel, M. F., Berghout, A., & van der Gaag, R. (1989) · British Journal of Ophthalmology · doi:10.1136/bjo.73.8.639 · Cited by 721
Biology of the rantes/sis cytokine family
Schall, T. J. (1991) · Cytokine · doi:10.1016/1043-4666(91)90013-4 · Cited by 673
Autoimmune Thyroid Disease: Further Developments in Our Understanding*
WEETMAN, A. P., & McGREGOR, A. M. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-6-788 · Cited by 658
Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
Hancock, W. W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J. A., Smiley, S. T., Ling, M., Gerard, N. P., & Gerard, C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1515 · Cited by 617
Expanding the effector CD4 T-cell repertoire: the Th17 lineage
Harrington, L. E., Mangan, P. R., & Weaver, C. T. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.017 · Cited by 590
Yoshimura, T., Yuhki, N., Moore, S. K., Appella, E., Lerman, M. I., & Leonard, E. J. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80590-3 · Cited by 589
Tuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., & Mackay, I. R. (1993) · Diabetes · doi:10.2337/diab.42.2.359 · Cited by 581
Leucocyte-endothelial interactions and regulation of leucocyte migration
Adams, D. H., & Shaw, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92029-x · Cited by 575
Wolpe, S. D., Davatelis, G., Sherry, B., Beutler, B., Hesse, D. G., Nguyen, H. T., Moldawer, L. L., Nathan, C. F., Lowry, S. F., & Cerami, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.570 · Cited by 571
Walz, A., Peveri, P., Aschauer, H., & Baggiolini, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90432-3 · Cited by 505
A human T cell-specific molecule is a member of a new gene family.
Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., Clayberger, C., Davis, M. M., & Krensky, A. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.1018 · Cited by 495
Rabinovitch, A., & Suarez-Pinzon, W. L. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00492-9 · Cited by 466
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
Ghoreschi, K., Thomas, P., Breit, S., Dugas, M., Mailhammer, R., van Eden, W., van der Zee, R., Biedermann, T., Prinz, J., Mack, M., et al. (2003) · Nature Medicine · doi:10.1038/nm804 · Cited by 453
Alpha and β chemokines induce NK cell migration and enhance NK-mediated cytolysis
Taub, D. D., Sayers, T. J., Carter, C. R., & Ortaldo, J. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3877 · Cited by 449
Engelhardt, E., Toksoy, A., Goebeler, M., Debus, S., Bröcker, E.-B., & Gillitzer, R. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65699-4 · Cited by 435
Yoshie, O., Imai, T., & Nomiyama, H. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)78002-9 · Cited by 429
Rollins, B. J., Morrison, E. D., & Stiles, C. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.3738 · Cited by 428
Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines
Wolpe, S. D., & Cerami, A. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.14.2687068 · Cited by 424
Differential CC chemokine-induced enhancement of T helper cell cytokine production
Karpus, W. J., Lukacs, N. W., Kennedy, K. J., Smith, W. S., Hurst, S. D., & Barrett, T. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4129 · Cited by 413
CXC chemokines: the regulatory link between inflammation and angiogenesis
Romagnani, P., Lasagni, L., Annunziato, F., Serio, M., & Romagnani, S. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.02.006 · Cited by 409
Self-citationRegulation of the T cell response
Romagnani, S. (2006) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2006.02606.x · Cited by 401
Self-citationDelgado, M., Abad, C., Martinez, C., Leceta, J., & Gomariz, R. P. (2001) · Nature Medicine · doi:10.1038/87887 · Cited by 383
Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9775 · Cited by 379
Self-citationDonor-Derived Ip-10 Initiates Development of Acute Allograft Rejection
Hancock, W. W., Gao, W., Csizmadia, V., Faia, K. L., Shemmeri, N., & Luster, A. D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.975 · Cited by 373
Ten, S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.2909 · Cited by 350
Autoimmune Thyroid Disease: Developments in Our Understanding
WEETMAN, A. P., & MCGREGOR, A. M. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-2-309 · Cited by 340
Cooper, D. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411223112106 · Cited by 329
New Twists in Gene Regulation by Glucocorticoid Receptor: Is DNA Binding Dispensable?
Karin, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81177-0 · Cited by 327
Cutting Edge: Selective Usage of Chemokine Receptors by Plasmacytoid Dendritic Cells
Penna, G., Sozzani, S., & Adorini, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1862 · Cited by 323
Gasperini, S., Marchi, M., Calzetti, F., Laudanna, C., Vicentini, L. M., Olsen, H., Murphy, M., Liao, F., Farber, J. M., & Cassatella, M. A. (1999) · PubMed · Cited by 304
How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model
von Herrath, M. G., Dockter, J., & Oldstone, M. B. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90101-5 · Cited by 304
β cells are responsible for CXCR3-mediated T-cell infiltration in insulitis
Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Holländer, G. A., & Piali, L. (2002) · Nature Medicine · doi:10.1038/nm1202-792 · Cited by 301
Signal Transduction by the Chemokine Receptor CXCR3
Bonacchi, A., Romagnani, P., Romanelli, R. G., Efsen, E., Annunziato, F., Lasagni, L., Francalanci, M., Serio, M., Laffi, G., Pinzani, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010303200 · Cited by 300
Self-citationFarber, J. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5238 · Cited by 298
MARCOCCI, C., VITTI, P., CETANI, F., CATALANO, F., CONCETTI, R., & PINCHERA, A. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-209 · Cited by 297
Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., & Luster, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6503 · Cited by 296
Muller, A. F., Drexhage, H. A., & Berghout, A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0441 · Cited by 289
Autoimmune thyroid disease: new models of cell death in autoimmunity
Stassi, G., & De Maria, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri750 · Cited by 284
Sørensen, T. L., Trebst, C., Kivisäkk, P., Klaege, K. L., Majmudar, A., Ravid, R., Lassmann, H., Olsen, D. B., Strieter, R. M., Ransohoff, R. M., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00097-8 · Cited by 263
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
Muller, A. J., & Scherle, P. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1929 · Cited by 262
Franchimont, D., Galon, J., Gadina, M., Visconti, R., Zhou, Y.-J., Aringer, M., Frucht, D. M., Chrousos, G. P., & O’Shea, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1768 · Cited by 260
Gasperini, S., Marchi, M., Calzetti, F., Laudanna, C., Vicentini, L., Olsen, H., Murphy, M., Liao, F., Farber, J., & Cassatella, M. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4928 · Cited by 254
Immunogenetic and Clinical Characterization of Slowly Progressive IDDM
Kobayashi, T., Tamemoto, K., Nakanishi, K., Kato, N., Okubo, M., Kajio, H., Sugimoto, T., Murase, T., & Kosaka, K. (1993) · Diabetes Care · doi:10.2337/diacare.16.5.780 · Cited by 251
Salcedo, R., Resau, J. H., Halverson, D., Hudson, E. A., Dambach, M., Powell, D., Wasserman, K., & Oppenheim, J. J. (2000) · The FASEB Journal · doi:10.1096/fj.99-0963com · Cited by 245
Waisman, A., Ruiz, P. J., Hirschberg, D. L., Gelman, A., Oksenberg, J. R., Brocke, S., Mor, F., Cohen, I. R., & Steinman, L. (1996) · Nature Medicine · doi:10.1038/nm0896-899 · Cited by 237
Expression of chemokines and chemokine receptors during human renal transplant rejection
Segerer, S., Cui, Y. C., Eitner, F., Goodpaster, T. A., Hudkins, K. L., Mack, M., Cartron, J., Colin, Y., Schlöndorff, D., & Alpers, C. E. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80009-3 · Cited by 228
Gosset, P., Charbonnier, A.-S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A., & Trottein, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2857::aid-immu2857>3.0.co;2-x · Cited by 225
Weetman, A. P. (2004) · Autoimmunity · doi:10.1080/08916930410001705394 · Cited by 221
Wakelkamp, I. M. M. J., Bakker, O., Baldeschi, L., Wiersinga, W. M., & Prummel, M. F. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01708.x · Cited by 221
CXC chemokines in angiogenesis of cancer
Strieter, R. M., Belperio, J. A., Phillips, R. J., & Keane, M. P. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.006 · Cited by 218
Melter, M., Exeni, A., Reinders, M. E. J., Fang, J. C., McMahon, G., Ganz, P., Hancock, W. W., & Briscoe, D. M. (2001) · Circulation · doi:10.1161/hc4601.098010 · Cited by 210
Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease
Lovett-Racke, A. E., Hussain, R. Z., Northrop, S., Choy, J., Rocchini, A., Matthes, L., Chavis, J. A., Diab, A., Drew, P. D., & Racke, M. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5790 · Cited by 207
Recruitment of lymphocytes to the human liver
Lalor, P. F., Shields, P., Grant, A. J., & Adams, D. H. (2002) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2002.01062.x · Cited by 204
Bonecchi, R., Sozzani, S., Stine, J. T., Luini, W., D’Amico, G., Allavena, P., Chantry, D., & Mantovani, A. (1998) · Blood · doi:10.1182/blood.v92.8.2668 · Cited by 204
Agostini, C., Calabrese, F., Rea, F., Facco, M., Tosoni, A., Loy, M., Binotto, G., Valente, M., Trentin, L., & Semenzato, G. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64126-0 · Cited by 203
C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.
Maghazachi, A. A., al-Aoukaty, A., & Schall, T. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.4969 · Cited by 202
Hiromatsu, Y. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1194 · Cited by 190
Elevation of CXCR3-Binding Chemokines in Urine Indicates Acute Renal-Allograft Dysfunction
Hu, H., Aizenstein, B. D., Puchalski, A., Burmania, J. A., Hamawy, M. M., & Knechtle, S. J. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00354.x · Cited by 180
Sato, K., Yamazaki, K., Shizume, K., Kanaji, Y., Obara, T., Ohsumi, K., Demura, H., Yamaguchi, S., & Shibuya, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118164 · Cited by 179
Christen, U., McGavern, D. B., Luster, A. D., von Herrath, M. G., & Oldstone, M. B. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6838 · Cited by 178
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
Butera, D., Marukian, S., Iwamaye, A. E., Hembrador, E., Chambers, T. J., Di Bisceglie, A. M., Charles, E. D., Talal, A. H., Jacobson, I. M., Rice, C. M., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0126 · Cited by 178
Inhibition of IFN-γ Signaling by Glucocorticoids
Hu, X., Li, W.-P., Meng, C., & Ivashkiv, L. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4833 · Cited by 177
Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo
Annunziato, F., Cosmi, L., Galli, G., Beltrame, C., Romagnani, P., Manetti, R., Romagnani, S., & Maggi, E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.5.691 · Cited by 176
Self-citationJanatpour, M. J., Hudak, S., Sathe, M., Sedgwick, J. D., & McEvoy, L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1375 · Cited by 175
Franciotta, D., Martino, G., Zardini, E., Furlan, R., Bergamaschi, R., Andreoni, L., & Cosi, V. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00261-2 · Cited by 174
de Carli, M. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.5.1120 · Cited by 171
F., N., I., C., Mauro, M. D., Marco, R. D., M., M., K., B., A., M., & R., G. (2002) · Diabetologia · doi:10.1007/s00125-002-0879-5 · Cited by 168
Expression of IFN-inducible protein-10 in chronic hepatitis
Narumi, S., Tominaga, Y., Tamaru, M., Shimai, S., Okumura, H., Nishioji, K., Itoh, Y., & Okanoue, T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5536 · Cited by 167
Wang, X., Yue, T.-L., Ohlstein, E. H., Sung, C.-P., & Feuerstein, G. Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24286 · Cited by 167
CC chemokines induce the generation of killer cells from CD56+ cells
Maghazachi, A. A., Al‐Aoukaty, A., & Schall, T. J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260207 · Cited by 163
Elevated Serum IP-10 Levels Observed in Type 1 Diabetes
Shimada, A., Morimoto, J., Kodama, K., Suzuki, R., Oikawa, Y., Funae, O., Kasuga, A., Saruta, T., & Narumi, S. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.510 · Cited by 162
Romagnani, P., Rotondi, M., Lazzeri, E., Lasagni, L., Francalanci, M., Buonamano, A., Milani, S., Vitti, P., Chiovato, L., Tonacchera, M., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64171-5 · Cited by 161
Self-citationMyhre, A. G., Undlien, D. E., Løvås, K., Uhlving, S., Nedrebø, B. G., Fougner, K. J., Trovik, T. S., Sørheim, J. I., & Husebye, E. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.618 · Cited by 160
García-López, M. Á., Sancho, D., Sánchez‐Madrid, F., & Marazuela, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7953 · Cited by 157
Rapoport, B., & McLachlan, S. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14321 · Cited by 152
Ehlert, J. E., Addison, C. A., Burdick, M. D., Kunkel, S. L., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6234 · Cited by 150
Mahad, D., Howell, S. J., & Woodroofe, M. N. (2002) · PubMed · doi:10.1136/jnnp.72.4.498 · Cited by 149
Aniszewski, J. P., Valyasevi, R. W., & Bahn, R. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6333 · Cited by 149
Antonelli, A., Rotondi, M., Ferrari, S. M., Fallahi, P., Romagnani, P., Franceschini, S. S., Serio, M., & Ferrannini, E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1689 · Cited by 148
Self-citationChristen, U., Wolfe, T., Möhrle, U., Hughes, A. C., Rodrigo, E., Green, E. A., Flavell, R. A., & von Herrath, M. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7023 · Cited by 148
Matz, M., Beyer, J., Wunsch, D., Mashreghi, M., Seiler, M., Pratschke, J., Babel, N., Volk, H., Reinke, P., & Kotsch, K. (2006) · Kidney International · doi:10.1038/sj.ki.5000343 · Cited by 147
Platelet Factor 4: An Inhibitor of Angiogenesis
Bikfalvi, A. (2004) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-831051 · Cited by 144
Salvi, M., Pedrazzoni, M., Girasole, G., Giuliani, N., Minelli, R., Wall, & Roti, E. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430197 · Cited by 143
Nishioji, K., Okanoue, T., Itoh, Y., Narumi, S., Sakamoto, M., Nakamura, H., Morita, A., & Kashima, K. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01391.x · Cited by 139
EVIDENCE FOR AN EFFECT OF ANTITHYROID DRUGS ON THE NATURAL HISTORY OF GRAVES' DISEASE
Weetman, A. P., McGregor, A. M., & Hall, R. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb03456.x · Cited by 139
Interferon-α-Related Thyroid Disease: Pathophysiological, Epidemiological, and Clinical Aspects
Carella, C., Mazziotti, G., Amato, G., Braverman, L. E., & Roti, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0627 · Cited by 134
Grubeck‐Loebenstein, B., Buchan, G. S., Chantry, D., Kassal, H., Londei, M., Pirich, K., Barrett, K., Turner, M., Waldhäusl, W. K., & Feldmann, M. (1989) · PubMed Central · Cited by 132
Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression
Hancock, W. W., Wang, L., Ye, Q., Han, R., & Lee, I. T. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00103-1 · Cited by 130
Sørensen, T. L., Sellebjerg, F. T., Jensen, C. V., Strieter, R. M., & Ransohoff, R. M. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00327.x · Cited by 127
Molecular evolution of CXC chemokines: extant CXC chemokines originate from the CNS
Huising, M. O., Stet, R. J. M., Kruiswijk, C. P., Savelkoul, H. F. J., & Kemenade, B. M. L. V.-V. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00120-0 · Cited by 127
The Pathology of Autoimmune Thyroid Disease: A Review
LiVolsi, V. A. (1994) · Thyroid · doi:10.1089/thy.1994.4.333 · Cited by 126
Romagnani, P., Annunziato, F., Lazzeri, E., Cosmi, L., Beltrame, C., Lasagni, L., Galli, G., Francalanci, M., Manetti, R., Marra, F., et al. (2001) · Blood · doi:10.1182/blood.v97.3.601 · Cited by 125
Self-citationCXCR3/CXCR3 Ligand Biological Axis Impairs RENCA Tumor Growth by a Mechanism of Immunoangiostasis
Pan, J., Burdick, M. D., Belperio, J. A., Xue, Y., Gerard, C. J., Sharma, S. P., Dubinett, S. M., & Strieter, R. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1456 · Cited by 124
Romagnani, P., Lazzeri, E., Lasagni, L., Mavilia, C., Beltrame, C., Francalanci, M., Rotondi, M., Annunziato, F., Maurenzig, L., Cosmi, L., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v13153 · Cited by 124
Self-citationIncrease in Circulating Levels of Monocyte Chemoattractant Protein-1 with Aging
Inadera, H., Egashira, K., Takemoto, M., Ouchi, Y., & Matsushima, K. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313127 · Cited by 122
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production
Romagnani, P., Maggi, L., Mazzinghi, B., Cosmi, L., Lasagni, L., Liotta, F., Lazzeri, E., Angeli, R., Rotondi, M., Filì, L., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.035 · Cited by 117
Self-citationFrom naive to effector ‐ alterations with aging
Linton, P., Haynes, L., Tsui, L., Zhang, X. M., & Swain, S. L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01023.x · Cited by 117
Laureti, S., Bellis, A. D., Muccitelli, V. I., Calcinaro, F., Bizzarro, A., Rossi, R., Bellastella, A., Santeusanio, F., & Falorni, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5149 · Cited by 117
Hypothyroidism in transgenic mice expressing IFN-γ in the thyroid
Caturegli, P., Hejazi, M., Suzuki, K., Dohán, O., Carrasco, N., Kohn, L. D., & Rose, N. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.020522597 · Cited by 115
Yang, J., & Richmond, A. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.01.010 · Cited by 115
Role for Interactions Between IP-10/Mig and CXCR3 in Proliferative Glomerulonephritis
Romagnani, P., Beltrame, C., Annunziato, F., Lasagni, L., Luconi, M., Galli, G., Cosmi, L., Maggi, E., Salvadori, M., Pupilli, C., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10122518 · Cited by 113
Self-citationSeewaldt, S., Thomas, H. E., Ejrnaes, M., Christen, U., Wolfe, T., Rodrigo, E., Coon, B., Michelsen, B. K., Kay, T. W. H., & von Herrath, M. G. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1801 · Cited by 112
CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
Lazzeri, E., & Romagnani, P. (2005) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008053174723 · Cited by 111
Self-citationRoura‐Mir, C., Catálfamo, M., Sospedra, M., Alcalde, L., Pujol‐Borrell, R., & Jaraquemada, D. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271228 · Cited by 111
Fahmy, N. M., Yamani, M. H., Starling, R. C., Ratliff, N. B., Young, J. B., McCarthy, P. M., Feng, J., Novick, A. C., & Fairchild, R. L. (2003) · Transplantation · doi:10.1097/00007890-200301150-00013 · Cited by 110
Antonelli, A., Rotondi, M., Fallahi, P., Romagnani, P., Ferrari, S. M., Buonamano, A., Ferrannini, E., & Serio, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0977 · Cited by 110
Self-citationPrimary structure of human platelet factor 4
Walz, D. A., Wu, V.-Y., de Lamo, R., Dene, H., & McCoy, L. E. (1977) · Thrombosis Research · doi:10.1016/0049-3848(77)90117-7 · Cited by 109
Analysis of cytokine gene expression in Graves' disease and multinodular goiter
Watson, P. F., Pickerill, A. P., Davies, R., & Weetman, A. P. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.8045947 · Cited by 109
Gambelunghe, G., Forini, F., Laureti, S., Murdolo, G., Toraldo, G., Santeusanio, F., Brunetti, P., Sanjeevi, C. B., & Falorni, A. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00983.x · Cited by 107
Díez, J. J., Hernánz, Á., Medina, S., Bayón, C., & Iglesias, P. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01629.x · Cited by 107
Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies.
De Bellis, A., Bizzarro, A., Rossi, R., Paglionico, V. A., Criscuolo, T., Lombardi, G., & Bellastella, A. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.4.8473373 · Cited by 106
Determinants of autoimmune thyroid disease
Weetman, A. P. (2001) · Nature Immunology · doi:10.1038/ni0901-769 · Cited by 104
Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis
Ajjan, R., Watson, P. F., McIntosh, R. S., & Weetman, A. P. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-784.x · Cited by 100
Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy
Wakelkamp, I. M. M. J., Gerding, M. N., Meer, J. W. C. V. D., Prummel, M. F., & Wiersinga, W. M. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01335.x · Cited by 98
Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders?
Romagnani, S. (2005) · Allergy · doi:10.1111/j.1398-9995.2006.01005.x · Cited by 97
Self-citationLazzeri, E., Rotondi, M., Mazzinghi, B., Lasagni, L., Buonamano, A., Rosati, A., Pradella, F., Fossombroni, V., La Villa, G., Gacci, M., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000160759.85080.2e · Cited by 96
Self-citationFalorni, A., Laureti, S., Bellis, A. D., Zanchetta, R., Tiberti, C., Arnaldi, G., Bini, V., Beck‐Peccoz, P., Bizzarro, A., Dotta, F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030954 · Cited by 94
Rotondi, M., Rosati, A., Buonamano, A., Lasagni, L., Lazzeri, E., Pradella, F., Fossombroni, V., Cirami, C., Liotta, F., La Villa, G., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00525.x · Cited by 92
Self-citationDetection and localization of chemokine gene expression in autoimmune thyroid disease
Kemp, E. H., Metcalfe, R., Smith, K. A., Woodroofe, M. N., Watson, P. F., & Weetman, A. P. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01824.x · Cited by 91
CXCR3 expression in human central nervous system diseases
Goldberg, S. H., van der Meer, P., Hesselgesser, J., Jaffer, S., Kolson, D. L., Albright, A. V., González‐Scarano, F., & Lavi, E. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00312.x · Cited by 89
Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells
WEETMAN, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92171-b · Cited by 88
Cloning and characterization of a novel T cell activation gene.
Burd, P. R., Freeman, G. J., Wilson, S. D., Berman, M. L., DeKruyff, R. H., Billings, P. R., & Dorf, M. E. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3126 · Cited by 85
Antonelli, A., Rotondi, M., Fallahi, P., Romagnani, P., Ferrari, S. M., Paolicchi, A., Ferrannini, E., & Serio, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01847 · Cited by 85
Self-citationAllergic humans are hypo‐responsive to CXCR3 chemokines in a Th1 immunity‐promoting loop
Campbell, D., Gangur, V., Simons, F. E. R., & HayGlass, K. T. (2003) · The FASEB Journal · doi:10.1096/fj.02-0908fje · Cited by 84
Wang, S. H., Bretz, J. D., Phelps, E., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2470 · Cited by 84
Analysis of orbital T cells in thyroid-associated ophthalmopathy
Förster, G. J., Otto, E., Hansen, C., Ochs, K., & Kahaly, G. J. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00613.x · Cited by 84
Role for interferon-γ inducible chemokines in endocrine autoimmunity: An expanding field
Rotondi, M., Lazzeri, E., Romagnani, P., & Serio, M. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345149 · Cited by 83
Self-citationIncrease of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing
Antonelli, A., Rotondi, M., Fallahi, P., Ferrari, S. M., Paolicchi, A., Romagnani, P., Serio, M., & Ferrannini, E. (2006) · Cytokine · doi:10.1016/j.cyto.2006.03.012 · Cited by 80
Self-citationAn Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes
Hanifi-Moghaddam, P., Schloot, N. C., Kappler, S., Seiβler, J., & Kolb, H. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1137 · Cited by 79
Thyroid follicular cells produce interleukin-8
Weetman, A. P., Bennett, G. L., & Wong, W. L. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1619027 · Cited by 78
Morimoto, J., Yoneyama, H., Shimada, A., Shigihara, T., Yamada, S., Oikawa, Y., Matsushima, K., Saruta, T., & Narumi, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.7017 · Cited by 74
Intravenous Immunoglobulin versus Corticosteroid in Treatment of Graves' Ophthalmopathy
Baschieri, L., Antonelli, A., NARDI, S., ALBERTI, B., Lepri, A., Canapicchi, R., & Fallahi, P. (1997) · Thyroid · doi:10.1089/thy.1997.7.579 · Cited by 72
Antonelli, A., Fallahi, P., Rotondi, M., Ferrari, S. M., Romagnani, P., Grosso, M., Ferrannini, E., & Serio, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02137 · Cited by 71
Self-citationIP-10 and Type 1 Diabetes: A Question of Time and Location
Christen, U., & von Herrath, M. G. (2004) · Autoimmunity · doi:10.1080/08916930410001713124 · Cited by 70
Elner, S. G. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.12.1597 · Cited by 70
Antonelli, A., Rotondi, M., Fallahi, P., Romagnani, P., Ferrari, S. M., Barani, L., Ferrannini, E., & Serio, M. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02447.x · Cited by 69
Self-citationMarazuela, M., Postigo, A. A., Acevedo, A., et al. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241034 · Cited by 68
Akalin, E., DIKMAN, S. H., Murphy, B. T., Bromberg, J. S., & Hancock, W. W. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00151.x · Cited by 67
Rotondi, M., Oliviero, A., Profice, P., Mone, C. M., Biondi, B., Buono, A. D., Mazziotti, G., Sinisi, A. M., Bellastella, A., & Carella, C. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03348040 · Cited by 63
Self-citationAntonelli, A., Rotondi, M., Fallahi, P., Grosso, M., Boni, G., Ferrari, S. M., Romagnani, P., Serio, M., Mariani, G., & Ferrannini, E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1571 · Cited by 62
Self-citationLow dose (1 μg) ACTH test in the evaluation of adrenal dysfunction in pre‐clinical Addison's disease
Laureti, S., Arvat, E., Candeloro, P., Vito, L. D., Ghigo, E., Santeusanio, F., & Falorni, A. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01050.x · Cited by 60
Rotondi, M., Falorni, A., Bellis, A. D., Laureti, S., Ferruzzi, P., Romagnani, P., Buonamano, A., Lazzeri, E., Crescioli, C., Mannelli, M., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1062 · Cited by 59
Self-citationZhang, Z., Kaptanoğlu, L., Haddad, W., Ivancic, D. Z., Alnadjim, Z., Hurst, S. D., Tishler, D. S., Luster, A. D., Barrett, T. A., & Fryer, J. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3205 · Cited by 58
Biddison, W. E., Cruikshank, W. W., Pelfrey, C. M., Taub, D. D., & Turner, R. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.444 · Cited by 58
Antonelli, A., Fallahi, P., Rotondi, M., Ferrari, S., Serio, M., & Miccoli, P. (2006) · British journal of surgery · doi:10.1002/bjs.5401 · Cited by 58
Self-citationSchaefer, K. L., Denevich, S., Ma, C., Cooley, S. R., Nakajima, A., Wada, K., Schlezinger, J. J., Sherr, D. H., & Saubermann, L. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160770.94199.9b · Cited by 56
T and B cell reactivity to adrenal antigens in autoimmune Addison's disease
FREEMAN, M., & Weetman, A. P. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb03073.x · Cited by 54
Laureti, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3507 · Cited by 53
Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth
Shen, H., Schuster, R. M., Lu, B., Waltz, S. E., & Lentsch, A. B. (2006) · The Prostate · doi:10.1002/pros.20476 · Cited by 52
Hubbard, V. M., Eng, J. M., Ramirez‐Montagut, T., Tjoe, K. H., Muriglan, S. J., Kochman, A. A., Terwey, T. H., Willis, L. M., Schiro, R., Heller, G., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0410 · Cited by 50
Watson, P. F., Pickerill, A. P., Davies, R., et al. (1995) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0150011 · Cited by 47
Itoh, Y., Morita, A., Nishioji, K., Narumi, S., Toyama, T., Daimon, Y., Nakamura, H., Kirishima, T., & Okanoue, T. (2001) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2001.00309.x · Cited by 47
Grey scale thyroid ultrasonography in the evaluation of patients with Graves' disease
Vitti, P. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420022 · Cited by 46
Expression Pattern of CXCR3, CXCR4, and CCR3 Chemokine Receptors in the Developing Human Brain
van der Meer, P., Goldberg, S. H., Fung, K. M., Sharer, L. R., González‐Scarano, F., & Lavi, E. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.1.25 · Cited by 46
Apolinario, A., Moisés Diago, M., Iacono, O. L., Lorente, R., Pérez, C., Majano, P. L., Clemente, G., & García‐Monzón, C. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01872.x · Cited by 42
Proinflammatory cytokine levels in hyperthyroidism.
Şentürk, T., Kozacı, L. D., Kok, F. J., Kadıköylü, G., & Bolaman, Z. (2003) · PubMed · Cited by 41
Expression of monocyte chemoattractant protein‐1 mRNA and protein in cultured human thyrocytes
Kasai, K., Banba, N., Motohashi, S., Hattori, Y., Manaka, K., & Shimoda, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00935-0 · Cited by 38
Goulvestre, C., Batteux, F., & Charreire, J. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200212)32:12<3435::aid-immu3435>3.0.co;2-5 · Cited by 36
Mimura, L. Y., Villares, S. M., Monteiro, M. L. R., Guazzelli, I. C., & BLOISE, W. (2003) · Thyroid · doi:10.1089/105072503322401032 · Cited by 36
Ashhab, Y., Domı́nguez, O., Sospedra, M., Roura‐Mir, C., Lucas, A., & Pujol‐Borrell, R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2873 · Cited by 35
Yoh, K., Shibuya, K., Morito, N., Nakano, T., Ishizaki, K., Shimohata, H., Nose, M., Izui, S., Shibuya, A., Kôyama, A., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000086473.23379.25 · Cited by 35
Cited by
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288
Self-citationCXCL10 and autoimmune diseases
Lee, E. Y., Lee, Z.-H., & Song, Y. W. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.12.002 · Cited by 357
CXCR3, Inflammation, and Autoimmune Diseases
Lacotte, S., Brun, S., Muller, S., & Dumortier, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04813.x · Cited by 339
Alopecia areata: A multifactorial autoimmune condition
Simakou, T., Butcher, J. P., Reid, S., & Henriquez, F. L. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.12.001 · Cited by 309
Chemotaxis, chemokine receptors and human disease
Jin, T., Xu, X., & Hereld, D. (2008) · Cytokine · doi:10.1016/j.cyto.2008.06.017 · Cited by 283
Metadata
- Authors
- Rotondi, M., Chiovato, L., Romagnani, S., Serio, M., & Romagnani, P.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2007-08-01
- Volume
- 28
- Issue
- 5
- Pages
- 492-520
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2111700007
- Cited by
- 257
- References
- 213
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.